These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8309016)

  • 1. Biotechnology industry calls for active US role.
    Marwick C
    JAMA; 1994 Mar; 271(9):648. PubMed ID: 8309016
    [No Abstract]   [Full Text] [Related]  

  • 2. The US biotechnology industry: an analysis of trends.
    Dibner MD
    Aust J Biotechnol; 1988 Sep; 2(2):129-32. PubMed ID: 2485326
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspective: Why communication in biotechnology is important.
    Gassen HG
    Biotechnol J; 2007 Sep; 2(9):1051-2. PubMed ID: 17768767
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing patent strategies: what will they mean for the industry?
    Mills AE; Tereskerz PM
    Nat Biotechnol; 2007 Aug; 25(8):867-8. PubMed ID: 17687359
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into US public biotech sector using patenting trends.
    Aggarwal S; Gupta V; Bagchi-Sen S
    Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lee Lynd.
    Lynd L
    Nat Biotechnol; 2011 Mar; 29(3):196. PubMed ID: 21390015
    [No Abstract]   [Full Text] [Related]  

  • 7. What will replace the tech economy?
    Davis S; Meyer C
    Time; 2000 May; 155(21):76-7. PubMed ID: 11765521
    [No Abstract]   [Full Text] [Related]  

  • 8. BIO reaches adolescence.
    Fox JL
    Nat Biotechnol; 2006 Apr; 24(4):381-3. PubMed ID: 16601712
    [No Abstract]   [Full Text] [Related]  

  • 9. Number crunching.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894180
    [No Abstract]   [Full Text] [Related]  

  • 10. Electoral campaign delays resolution of biotech issues.
    Fox JL
    Nat Biotechnol; 2004 Oct; 22(10):1193. PubMed ID: 15470439
    [No Abstract]   [Full Text] [Related]  

  • 11. US biotechnology companies and foreign nationals: the changing dynamics of access to H-1B visas.
    Dahms AS; Trow SC
    Nat Biotechnol; 2005 May; 23(5):629-30. PubMed ID: 15877077
    [No Abstract]   [Full Text] [Related]  

  • 12. Imagining the future: what will the medical technology field look like.
    Gieras I; Corzine J; Dreps D; Fraai M; Grimes S; Hertzler L
    Biomed Instrum Technol; 2008; 42(6):433-4, 436-40. PubMed ID: 19012450
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Renaissance' seen in drug development.
    Wagner M
    Mod Healthc; 1993 Feb; 23(6):31. PubMed ID: 10183824
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech patenting matures.
    Lawrence S
    Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry trends. Biotechnology in 1998 and beyond.
    Persidis A
    Nat Biotechnol; 1998 Dec; 16(13):1378-9. PubMed ID: 9853624
    [No Abstract]   [Full Text] [Related]  

  • 17. Regenerative medicine. The industry comes of age.
    Mason C
    Med Device Technol; 2007; 18(2):25-30. PubMed ID: 17494498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industrial biotechnology-a chance at redemption.
    Herrera S
    Nat Biotechnol; 2004 Jun; 22(6):671-5. PubMed ID: 15175684
    [No Abstract]   [Full Text] [Related]  

  • 20. Industrial biotechnology - past, present and future.
    Wohlgemuth R
    N Biotechnol; 2012 Jan; 29(2):165. PubMed ID: 22154940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.